Aurinia Pharmaceuticals Inc. Operating Lease, Payments in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2024.
  • Aurinia Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $276K, a 4.94% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Operating Lease, Payments for 2024 was $1.1M, unchanged from 2023.
  • Aurinia Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $1.1M, a 8.33% decline from 2022.
  • Aurinia Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $1.2M, a 85.8% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

Aurinia Pharmaceuticals Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $276K +$13K +4.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $263K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02

Aurinia Pharmaceuticals Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.1M $0 0% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $1.1M -$100K -8.33% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $1.2M +$554K +85.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $646K +$379K +142% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $267K +$85K +46.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $182K +$31K +20.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $151K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.